PT1553178E - Vírus oncolítico que cresce selectivamente em células tumorais - Google Patents

Vírus oncolítico que cresce selectivamente em células tumorais Download PDF

Info

Publication number
PT1553178E
PT1553178E PT37412228T PT03741222T PT1553178E PT 1553178 E PT1553178 E PT 1553178E PT 37412228 T PT37412228 T PT 37412228T PT 03741222 T PT03741222 T PT 03741222T PT 1553178 E PT1553178 E PT 1553178E
Authority
PT
Portugal
Prior art keywords
tumor cells
oncolytic virus
virus growing
growing selectively
selectively
Prior art date
Application number
PT37412228T
Other languages
English (en)
Inventor
Toshiyoshi Fujiwara
Satoru Kyo
Yoshiko Shirakiya
Takeshi Kawashima
Noriaki Tanaka
Original Assignee
Oncolys Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolys Biopharma Inc filed Critical Oncolys Biopharma Inc
Publication of PT1553178E publication Critical patent/PT1553178E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT37412228T 2002-07-08 2003-07-07 Vírus oncolítico que cresce selectivamente em células tumorais PT1553178E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002198941A JP3867968B2 (ja) 2002-07-08 2002-07-08 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス

Publications (1)

Publication Number Publication Date
PT1553178E true PT1553178E (pt) 2014-06-12

Family

ID=30112441

Family Applications (1)

Application Number Title Priority Date Filing Date
PT37412228T PT1553178E (pt) 2002-07-08 2003-07-07 Vírus oncolítico que cresce selectivamente em células tumorais

Country Status (15)

Country Link
US (1) US20060239967A1 (pt)
EP (1) EP1553178B1 (pt)
JP (1) JP3867968B2 (pt)
KR (2) KR20050075867A (pt)
CN (1) CN100430476C (pt)
AU (1) AU2003281310B2 (pt)
CA (1) CA2491907C (pt)
DK (1) DK1553178T3 (pt)
ES (1) ES2455127T3 (pt)
HK (1) HK1082958A1 (pt)
NZ (1) NZ537631A (pt)
PL (1) PL374644A1 (pt)
PT (1) PT1553178E (pt)
WO (1) WO2004005511A1 (pt)
ZA (1) ZA200500047B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473418B2 (en) * 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
EP1745801A1 (en) * 2004-05-13 2007-01-24 Daiichi Pharmaceutical Co., Ltd. Method of inhibiting telomerase activity and inhibitor
CN100361710C (zh) * 2004-06-07 2008-01-16 成都康弘生物科技有限公司 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用
US7943373B2 (en) * 2004-09-29 2011-05-17 Oncolys Biopharma, Inc. Telomelysin/GFP-expressing recombinant virus
JPWO2006085689A1 (ja) * 2005-02-10 2008-06-26 オンコリスバイオファーマ株式会社 テロメライシン併用抗癌剤
JP5069871B2 (ja) * 2006-05-30 2012-11-07 シスメックス株式会社 新規な癌細胞検出試料調製用キット及びそれを用いた癌細胞検出用キット
WO2008065726A1 (fr) * 2006-11-29 2008-06-05 Oncolys Biopharma Inc. Agent contenant du télomelysin destiné à rompre la tolérance anti-tumorale
JP5580043B2 (ja) * 2007-04-27 2014-08-27 オンコリスバイオファーマ株式会社 放射線増感増強剤
US20090181931A1 (en) * 2008-01-16 2009-07-16 Oncolys Biopharma, Inc. Antiviral activity of cidofovir against oncolytic viruses
US20110250588A1 (en) 2008-12-18 2011-10-13 Sysmex Corporation Method for detecting cancer cells in blood sample
US9645154B2 (en) 2010-12-24 2017-05-09 Arkray, Inc. Method for detecting cancer cell
CN106591368A (zh) * 2016-10-12 2017-04-26 郑州大学 携带il‑15r/il‑15融合基因的b亚群腺病毒11载体及其构建和用途
EP3695846B1 (en) 2017-10-10 2023-11-29 Yamaguchi University Enhancer for t-cells or b-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in t-cells or b-cells
CN113993531A (zh) * 2019-05-14 2022-01-28 癌康理生物制药株式会社 向肿瘤组织施加溶瘤病毒的方法以及施加用装置
TW202130656A (zh) 2019-10-28 2021-08-16 日商諾伊爾免疫生物科技股份有限公司 用以治療癌症的醫藥、組合醫藥、醫藥組成物、免疫反應性細胞、核酸輸送媒體、及製品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1275299A (en) * 1997-10-23 1999-05-10 Uab Research Foundation Human papillomavirus vectors for the episomal transduction of host cells and method of making same
EP1147181B1 (en) * 1999-02-04 2004-05-12 Geron Corporation Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
US6692736B2 (en) * 2000-03-24 2004-02-17 Cell Genesys, Inc. Cell-specific adenovirus vectors comprising an internal ribosome entry site
AU4764801A (en) * 2000-03-24 2001-10-08 Calydon Inc Cell-specific adenovirus vectors comprising an internal ribosome entry site
IL152420A0 (en) * 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
CN1177042C (zh) * 2001-04-12 2004-11-24 上海华康生物技术有限公司 共表达人p53基因和人细胞因子基因的重组腺病毒及其制法和用途
CN1195056C (zh) * 2001-07-12 2005-03-30 钱其军 一种在肿瘤细胞中特异性增殖及高效表达抗癌基因的重组病毒及其构建方法

Also Published As

Publication number Publication date
KR100947194B1 (ko) 2010-03-11
PL374644A1 (en) 2005-10-31
CA2491907A1 (en) 2004-01-15
ES2455127T3 (es) 2014-04-14
JP3867968B2 (ja) 2007-01-17
CA2491907C (en) 2013-03-19
AU2003281310B2 (en) 2008-02-21
CN100430476C (zh) 2008-11-05
CN1665927A (zh) 2005-09-07
ZA200500047B (en) 2006-05-31
JP2004033186A (ja) 2004-02-05
AU2003281310A1 (en) 2004-01-23
NZ537631A (en) 2007-05-31
EP1553178A4 (en) 2006-03-29
KR20090043589A (ko) 2009-05-06
EP1553178B1 (en) 2014-03-05
KR20050075867A (ko) 2005-07-22
US20060239967A1 (en) 2006-10-26
WO2004005511A1 (ja) 2004-01-15
EP1553178A1 (en) 2005-07-13
DK1553178T3 (da) 2014-05-19
HK1082958A1 (en) 2006-06-23

Similar Documents

Publication Publication Date Title
HK1082958A1 (en) Tumor-lysing virus growing selectively in tumor cells
HK1181815A1 (zh) 基因組被修飾的細胞
EP1644135A4 (en) IMPROVED SOLAR CELLS
EP1488816A4 (en) CLOSED CELL CULTURE SYSTEM
IL173165A0 (en) Cell cultivation and breeding method
EP1723238A4 (en) MODIFIED ONCOLYTIC VIRUSES
AU2003260351A8 (en) Cell culture insert
GB2404665B (en) Cell culture
AU2003258061A8 (en) Therapeutic inhibitionof protein kinases in cancer cells
GB0206461D0 (en) Improvements in vaccination
AU2003290432A8 (en) T cell activating gene
AU2001231204A1 (en) Genetically engineered tumor cell vaccines
EP1543129A4 (en) VIRUS-INDUCED GENE SILENCING IN PLANTS
AU2003216822A8 (en) Stem cell culture
AU2003291751A8 (en) Non-phosphorous-linked oligomeric compounds and their use in gene modulation
EP1572084A4 (en) MAMMALIAN GENES INVOLVED IN THE SUPPRESSION OF VIRAL INFECTIONS AND TUMORS
AU2003223089A8 (en) Compositions and methods for treating cancer with an oncolytic viral agent
ZA200506732B (en) Cell culture
GB2422843B (en) Cell culture base
ZA200501352B (en) Cell culture surface
AU2003249912A1 (en) Peptides for inducing apoptosis in tumor cells
GB0217064D0 (en) Improvements in tranquilliser darts
AU2003230671A8 (en) Improvements in electrochemistry technical field
EP1563073A4 (en) PROTEIN PRODUCTION METHODS AND MODIFIED CELLS FOR USE IN SUCH METHODS
SG102044A1 (en) Cell culture system